CPIX 10-Q: SEC filing
Cumberland Pharmaceuticals
Filed with the SEC on · accession 0001087294-26-000079
CPIX filed a 10-Q (quarterly report) with the SEC on Nov 13, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -11.3% by the first close after the filing.
Summary of the filing
Cumberland Pharmaceuticals filed its Q3 2026 Form 10-Q, reporting quarterly financial results and disclosing that its FDA-approved brands segment was classified as held for sale as of April 22, 2026.
Key details
How CPIX stock reacted
Close before
$6.63
Nov 12, 2026
First close after
-11.31%
$5.88
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for CPIX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CPIX?
Click hereFrequently asked questions
What did CPIX file with the SEC on Nov 13, 2026?
CPIX filed a 10-Q (SEC filing). Cumberland Pharmaceuticals filed its Q3 2026 Form 10-Q, reporting quarterly financial results and disclosing that its FDA-approved brands segment was classified as held for sale as of April 22, 2026.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did CPIX stock react to this filing?
CPIX closed at $6.63 before the filing and $5.88 on Nov 13, 2026 (-11.31%).
Other CPIX SEC filings
Get alerts when CPIX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days